

Non-communicable diseases (NCDs) now account for seven of the world's ten leading causes of death and kill 18 million people each year before age 70 years. WHO recently launched a new investment case urging countries to scale up proven, cost-effective interventions. The analysis, Saving Lives, Spending Less, estimates that implementing WHO's “best buys” in 176 countries would cost about US$3 per person annually. By 2030, the package could save more than 12 million lives, prevent 28 million heart attacks and strokes, add 150 million healthy life-years, and generate around US$1 trillion in economic benefits.
Oncology
|31st Dec, 2025
|Journal of the American Medical Association
Oncology
|15th Jan, 2026
|The Lancet
Oncology
|15th Jan, 2026
|The Lancet
Oncology
|15th Jan, 2026
|The Lancet
Oncology
|15th Jan, 2026
|The Lancet
Oncology
|15th Jan, 2026
|The Lancet
Oncology
|15th Jan, 2026
|The Lancet